Technical Analysis for ARTL - Artelo Biosciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| 50 DMA Resistance | Bearish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| 50 DMA Resistance | Bearish | 3.79% | |
| Fell Below 20 DMA | Bearish | 3.79% | |
| MACD Bearish Signal Line Cross | Bearish | 3.79% | |
| 180 Bearish Setup | Bearish Swing Setup | 3.79% | |
| Calm After Storm | Range Contraction | 3.79% |
| Alert | Time |
|---|---|
| Possible Inside Day | 1 day ago |
| 1.5x Volume Pace | 1 day ago |
| 20 DMA Support | 1 day ago |
| 60 Minute Opening Range Breakout | 1 day ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Artelo Biosciences, Inc. is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system. Artelo is rapidly advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including cancer, pain, and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Pain Pharmacy Medication Inflammation Cannabinoid
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Pain Pharmacy Medication Inflammation Cannabinoid
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.98 |
| 52 Week Low | 1.16 |
| Average Volume | 12,178 |
| 200-Day Moving Average | 1.47 |
| 50-Day Moving Average | 1.42 |
| 20-Day Moving Average | 1.39 |
| 10-Day Moving Average | 1.44 |
| Average True Range | 0.09 |
| RSI (14) | 47.64 |
| ADX | 19.91 |
| +DI | 16.34 |
| -DI | 18.33 |
| Chandelier Exit (Long, 3 ATRs) | 1.32 |
| Chandelier Exit (Short, 3 ATRs) | 1.53 |
| Upper Bollinger Bands | 1.54 |
| Lower Bollinger Band | 1.23 |
| Percent B (%b) | 0.44 |
| BandWidth | 22.59 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.01 |
| MACD Histogram | -0.0043 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.46 | ||||
| Resistance 3 (R3) | 1.47 | 1.44 | 1.44 | ||
| Resistance 2 (R2) | 1.44 | 1.42 | 1.44 | 1.44 | |
| Resistance 1 (R1) | 1.41 | 1.41 | 1.39 | 1.40 | 1.43 |
| Pivot Point | 1.38 | 1.38 | 1.38 | 1.38 | 1.38 |
| Support 1 (S1) | 1.35 | 1.36 | 1.34 | 1.34 | 1.31 |
| Support 2 (S2) | 1.32 | 1.35 | 1.32 | 1.30 | |
| Support 3 (S3) | 1.29 | 1.32 | 1.30 | ||
| Support 4 (S4) | 1.28 |
